Mr Pascal AUZIERE France

Short Company Description:

Urgo Healthcare (Turnover of 156 M€, the Self Care Division of the privately owned URGO Group, 589 M€ / 3180 employees), has leading market positions in France and on international markets (81M€ is done on International Markets through our 22 subsidiaries and exclusive distributors).

Urgo Healthcare has a portofolio of 12 brands of which 4 are global:

  • URGO in First Aid

  • HUMEX and HUMER in Cough & Cold and Allergy

  • ALVITYL in Multivitamins

Other brands are AGAVE, ALPHREMA, MORDEX, SONODOR, NOVAFIX, SONALTO, INOTYOL and GOVITAL.

We are interested in:

Urgo Healthcare is interested in Licencing-In products (range extensions and breakthrough innovations) for its different brands to be promoted in France and its network of 80 countries.

We have the expertise in different types of regulatory status, whether OTC MA Drugs, Medical Devices, Electrical Devices, Biocides, Food Supplements or Cosmetics. We focus on self-medication products with strong clinical evidence.

We are mainly interested in the following products:

- Cough&Cold, ENT and Allergy OTC Drugs (based on chemical or natural ingredients)

- Cough&Cold, ENT and Allergy Medical Devices (based on natural ingredients)

- First aid (Ex: advanced wound care plasters, stop bleeding, burn injuries, innovative antiseptic solutions, insect bites, blisters, Filmogel Technology®)

- Pain management products (Electrotherapy devices, Creams, Gels, Hot&Cold Patches and Sport Injuries)

- Oral Care & Dental care

- Skin care (Including baby care)

- Foot care

- Veinotonic

- Gynecology care (vaginal dryness & infections, Pelvis pain, infertility …)

- Food Supplement for well being and vitality for all the family (Ex: Probiotics)

- Hearing discomfort devices (hearing loss, tinnitus …)

Website:
www.urgo.com
LABORATOIRES URGO HEALTHCARE
Strategic Business Development Director 

Mrs Alexandra Carrel France

Cabinet Carrel
Founding Partner 

Mrs Laurence CASSARINO France

SANOFI-AVENTI GROUP
Licensing-out Lead - Portfolio Enhancement & Maximisation Dpt 

Mr Benjamin Chambon France

Alira Health is an integrated healthcare consulting firm and fully registered investment bank that provides execution and transaction services, management, regulatory and clinical advisory services and operates in US, EU and Japan with 12 offices.

Our advantage lies in a team of Doctors, Bankers, Scientists and Management Consultants that armed with field specific knowledge make a difference when it comes to find and exploit pathways of growth in the healthcare market.

We work for large medtech, big pharma, biotech companies, digital health, and healthcare providers covering the whole healthcare value chain and we are proudly recognized at a top 8 consulting firms globally in the healthcare market and among the best consulting firms according to Forbes.

Mr Benjamin Chambon
ALIRA HEALTH SAS
LinkedIn logo Chief Operating Officer 

Mrs Sylvie Fondanayche France

SUBSTIPHARM
Head of Business Development 

Mrs Maria Teresa GALLARDO DOLS France

PIERRE FABRE MEDICAMENT
CORPORATE BD & LICENSING MANAGER 

Mr Vassilis Gazelos France

Ethypharm
Senior Director Business Development 

Dr Maxime Hassid France

Liberty Pharma group is a French family business specialised in the development and manufacturing of finished products, with various status, from pharmaceutical to food supplement.

We are offering a full service (MA Dossier + Supply) to partners willing to create and complement their range with products that we offer.

Among others, we are working with multinational companies such as Servier, Mylan, Teva, BMS, Sanofi, Sandoz which appreciate our full service reactivity and quality.

Liberty Pharma offers several kind of products. Our Product list, available on demand, features :
- Medical mouthwashes
- Cough and cold products : pharmaceutical, phytotherapy, medical device and also food supplement
- Gastro-enterology products : both pharmaceutical and phytotherapy
- Venous pathologies : Food supplement range
- Dermatology : Scabies treatment

Each dossier is fully developed internally and is available to be audited in our online platform. We are looking for partners interested by the MA Dossiers / finished products that we offer, with a supply full service in order to launch innovative and unique products or to complete an existing range.

Our standard business model is open to discussion but normally we sell directly MA Dossiers, to our partners, combined with a long-term supply contract.
We don't have any trademarks or sales force, nor interest in licensing-in.
Liberty Pharma
Export Director 

Mrs Claire KANONY-TRUC France

PIERRE FABRE MEDICAMENT
Corporate Business Dev. & Licensing Project Manager 

Mrs Hayfa Konrad France

Consultant

Roche Diagnostics GmbH

Hayfa Konrad
Lawyer